These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 11512311

  • 1. The kidney transplant program at the Bergamo Center.
    Remuzzi G, Perico N, Gotti E, Ruggenenti P, Rota G, Locatelli G.
    Clin Transpl; 2000; ():179-91. PubMed ID: 11512311
    [Abstract] [Full Text] [Related]

  • 2. The Bergamo Kidney Transplant Program.
    Perico N, Cravedi P, Ruggenenti P, Gotti E, Rota G, Locatelli G, Gambara V, Perna A, Rota S, Remuzzi G.
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
    Ruggenenti P, Cravedi P, Gotti E, Plati A, Marasà M, Sandrini S, Bossini N, Citterio F, Minetti E, Montanaro D, Sabadini E, Tardanico R, Martinetti D, Gaspari F, Villa A, Perna A, Peraro F, Remuzzi G.
    PLoS Med; 2021 Jun; 18(6):e1003668. PubMed ID: 34166370
    [Abstract] [Full Text] [Related]

  • 5. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 6. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G.
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [Abstract] [Full Text] [Related]

  • 7. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
    Cortinovis M, Gotti E, Pradini S, Gaspari F, Perico N.
    Transplantation; 2011 Sep 15; 92(5):550-6. PubMed ID: 21709602
    [Abstract] [Full Text] [Related]

  • 8. The use of mycophenolate mofetil in transplant recipients.
    Mele TS, Halloran PF.
    Immunopharmacology; 2000 May 15; 47(2-3):215-45. PubMed ID: 10878291
    [Abstract] [Full Text] [Related]

  • 9. A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
    Etienne I, Toupance O, Bénichou J, Thierry A, Al Najjar A, Hurault de Ligny B, Le Meur Y, Westeel PF, Marquet P, François A, Hellot MF, Godin M.
    Nephrol Dial Transplant; 2010 Sep 15; 25(9):3096-106. PubMed ID: 20299336
    [Abstract] [Full Text] [Related]

  • 10. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.
    Exp Clin Transplant; 2008 Mar 15; 6(1):48-53. PubMed ID: 18405245
    [Abstract] [Full Text] [Related]

  • 11. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 12. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, Rama I, Torras J.
    Transpl Int; 2003 Nov 20; 16(11):820-7. PubMed ID: 12879230
    [Abstract] [Full Text] [Related]

  • 13. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D, Khan R, Fragulidis GP, Nery JR, Ricordi C, Tzakis AG.
    Clin Transpl; 1996 Nov 20; ():187-201. PubMed ID: 9286568
    [Abstract] [Full Text] [Related]

  • 14. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
    Hazzan M, Labalette M, Copin MC, Glowacki F, Provôt F, Pruv FR, Noël C.
    J Am Soc Nephrol; 2005 Aug 15; 16(8):2509-16. PubMed ID: 15987748
    [Abstract] [Full Text] [Related]

  • 16. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 15; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 17. Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.
    Capone D, Tarantino G, Kadilli I, Polichetti G, Basile V, Federico S, Sabbatini M.
    Nephrol Dial Transplant; 2011 Sep 15; 26(9):3019-25. PubMed ID: 21317409
    [Abstract] [Full Text] [Related]

  • 18. Modifying cyclosporine associated renal allograft dysfunction.
    Mohapatra N, Vanikar AV, Patel RD, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2009 Sep 15; 20(5):770-4. PubMed ID: 19736471
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov 15; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

  • 20. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
    Lee CM, Markezich AJ, Scandling JD, Dafoe DC, Alfrey EJ.
    J Surg Res; 1998 May 15; 76(2):131-6. PubMed ID: 9698512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.